Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma

Autologous dendritic cell vaccine for estrogen receptor (ER)/progestin receptor (PR) double-negative breast cancer

Immunotherapy in ovarian cancer

Morphologic evidence of anti-tumor specificity of T cells activated by denritic cells derived from peripheral blood mononuclear cells of thyroid cancer patients

Dendritic cell vaccine modified by Ag85A gene enhances anti-tumor immunity against bladder cancer

Dendritic cell-based vaccination in metastatic melanoma patients: phase II clinical trial

Dendritic cell engineering for tumor immunotherapy: from biology to clinical translation

Immunotherapies for non-small-cell lung cancer and mesothelioma

Phase I immunotherapy trial using glioblastoma apoptotic body-pulsed dendritic cells.